Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Sep 26, 2024, 14:05 |
Blog
Stephen V Liu: Real-world study of first-line nivolumab and ipilimumab for pleural mesothelioma
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 25, 2024, 16:26 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Over the past weeks, we have proudly highlighted 40 extraordinary women shaping the future of…
Sep 24, 2024, 16:52 |
Blog
Assessment of the safety and efficacy of Balstilimab in combination with Botensilimab for NSCLC - Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: ''Assessment of the safety and efficacy…
Sep 24, 2024, 12:30 |
Societies
11 ESMO24 presentations published on NEJM
At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…
Sep 24, 2024, 11:04 |
Blog
Stephen V Liu: The recent FDA approval of the MARIPOSA-2 regimen for EGFR NSCLC
Stephen V Liu shared a post on X: ''In this episode of the IASLC podcast…
Sep 24, 2024, 09:00 |
Blog
Lykke Hinsch Gylvin: What makes a Medical / Science Congress visit truly energizing
Lykke Hinsch Gylvin posted on LinkedIn: "This is what makes a Medical / Science Congress…
Sep 23, 2024, 20:18 |
Blog
Antonio Passaro: Honored to have presented the SOHO-02 clinical trial
Antonio Passaro shared a post on LinkedIn: "I am truly honored to have presented the…
Sep 23, 2024, 09:48 |
Insight
Heidi Ko: Alarming Biomarker Testing Gaps in NSCLC
Heidi Ko, Medical Director, Medical Affairs, Labcorp Drug Development, posted the following on LinkedIn: “These…
Sep 23, 2024, 02:00 |
Insight
Insights on Genomics: Jemma Arakelyan Interviews Raju Kucherlapati during the CityU-AFCR Symposium
During the CityU-AFCR Symposium at BioHK 2024 on September 12-13, Dr. Jemma Arakelyan interviewed Dr.…
Sep 22, 2024, 15:15 |
Insight
Dexamethasone reduces IRRs in patients with EGFR-mutated NSCLC treated with intravenous RYBREVANT
Johnson and Johnson announced results from the open-label Phase 2 SKIPPirr study, which evaluated additional…
42
43
44
45
46
All:
851
Posts:
431 - 440
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube